ペイシェント・エンゲージメント・ソリューション市場：構成別、展開形態別、機能別、エンドユーザー別 世界の機会分析と産業予測 2023-2032年

ペイシェント・エンゲージメント・ソリューション市場は、2022年に170億米ドルと評価され、2023年から2032年にかけてCAGR 11.5%で成長し、2032年には505億米ドルに達すると推定されています。

各地域で自動化動向が重視されるようになったことが、ペイシェント・エンゲージメント・ソリューション市場の主な促進要因の1つとなっています。自動化ソリューションは、以下のような多くの有益な側面を提供します。

• 新規患者の登録と病歴のオンライン管理、予約のスケジューリングと再スケジューリングなど。また、テキストや音声メッセージによる自動予約リマインダーの送信も可能です。このように、ペイシェント・エンゲージメント・ソリューションが提供するリアルタイムの識別、モニタリング、応答機能に対する需要が伸びています。これらの要因が、ペイシェント・エンゲージメント・ソリューションの世界市場の成長をさらに促進すると予想されます。

さらに、同市場は、ペイシェント・エンゲージメント・ソリューションとサービスに関連する多額の費用から大きな影響を受けています。主に、予算に制約のある中小企業にとっては、こうした費用が足かせとなる可能性があります。中小企業は、ペイシェント・エンゲージメント・ソリューションを経済的負担と認識し、ヘルスケア対策への投資が不十分となる可能性があります。さらに、大規模な組織であっても、特に競合する予算需要に直面した場合、ペイシェント・エンゲージメント・ソリューションに多額のリソースを割り当てることにためらいを示す可能性があります。

ペイシェント・エンゲージメント・ソリューション市場にプラスの影響を与える注目すべき要因としては、人々のモバイルヘルスに関する意識の高まりや、電子カルテ（HER）レポート重視の高まりなどが挙げられます。しかし、ヘルスケアインフラに必要な大規模な投資や、既存のヘルスケアインフラコンポーネントと高度なソリューションの統合に伴う高い複雑性が、市場成長の妨げになることが多いです。しかし、遠隔患者モニタリングや支援サービスを提供するためのクラウドコンピューティング技術の重要性の高まりは、市場プレーヤーに有利な市場機会を提供しています。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 市場概要

• 市場の定義と範囲
• 主な調査結果
  • 影響要因
  • 主な投資機会
• ポーターのファイブフォース分析
• 市場力学
  • 促進要因
    • モバイルヘルスに対する人々の意識の高まり
    • 電子カルテ（EHR）レポート重視の高まり
  • 抑制要因
    • ヘルスケア・インフラへの大規模な投資が必要
    • 既存のヘルスケアインフラコンポーネントと高度なソリューションの統合に伴う高い複雑性
  • 機会
    • 遠隔患者モニタリングと支援サービスを提供するためのクラウドコンピューティング技術の重要性の高まり

第4章 ペイシェント・エンゲージメント・ソリューション市場：構成別

• 概要
• ハードウェア
• ソフトウェア
• サービス

第5章 ペイシェント・エンゲージメント・ソリューション市場：展開形態別

• 概要
• オンプレミス
• クラウド

第6章 ペイシェント・エンゲージメント・ソリューション市場：機能別

• 概要
• コミュニケーション
• ヘルストラッキングと洞察
• バイリングと支払い
• 管理
• その他

第7章 ペイシェント・エンゲージメント・ソリューション市場：エンドユーザー別

• 概要
• プロバイダー
• 支払者
• 患者

第8章 ペイシェント・エンゲージメント・ソリューション市場：地域別

• 概要
• 北米
  • 米国
  • カナダ
• 欧州
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • その他
• アジア太平洋
  • 中国
  • 日本
  • インド
  • オーストラリア
  • 韓国
  • その他
• ラテンアメリカ
  • ラテンアメリカ
  • 中東
  • アフリカ

第9章 競合情勢

• イントロダクション
• 主要成功戦略
• 主要10社の製品マッピング
• 競合ダッシュボード
• 競合ヒートマップ
• 主要企業のポジショニング（2022年）

第10章 企業プロファイル

• Aetna Inc.
• Allscripts Healthcare Solutions, Inc.（Veradigm LLC）
• Athenahealth
• Oracle Corporation
• EPIC Systems Corporation
• GetWellNetwork, Inc.
• IBM Corporation
• IQVIA Inc.
• Lumeon Inc.
• McKesson Corporation.

LIST OF TABLES

• TABLE 01. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 02. PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY REGION, 2022-2032 ($MILLION)
• TABLE 03. PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY REGION, 2022-2032 ($MILLION)
• TABLE 04. PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY REGION, 2022-2032 ($MILLION)
• TABLE 05. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 06. PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE, BY REGION, 2022-2032 ($MILLION)
• TABLE 07. PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD, BY REGION, 2022-2032 ($MILLION)
• TABLE 08. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 09. PATIENT ENGAGEMENT SOLUTIONS MARKET FOR COMMUNICATION, BY REGION, 2022-2032 ($MILLION)
• TABLE 10. PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH TRACKING AND INSIGHTS, BY REGION, 2022-2032 ($MILLION)
• TABLE 11. PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILING AND PAYMENTS, BY REGION, 2022-2032 ($MILLION)
• TABLE 12. PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ADMINISTRATIVE, BY REGION, 2022-2032 ($MILLION)
• TABLE 13. PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHERS, BY REGION, 2022-2032 ($MILLION)
• TABLE 14. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 15. PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY REGION, 2022-2032 ($MILLION)
• TABLE 16. PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY REGION, 2022-2032 ($MILLION)
• TABLE 17. PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY REGION, 2022-2032 ($MILLION)
• TABLE 18. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION, 2022-2032 ($MILLION)
• TABLE 19. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 20. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 21. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 22. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 23. NORTH AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 24. U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 25. U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 26. U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 27. U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 28. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 29. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 30. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 31. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 32. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 33. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 34. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 35. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 36. EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 37. UK PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 38. UK PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 39. UK PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 40. UK PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 41. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 42. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 43. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 44. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 45. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 46. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 47. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 48. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 49. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 50. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 51. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 52. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 53. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 54. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 55. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 56. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 57. REST OF EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 58. REST OF EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 59. REST OF EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 60. REST OF EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 61. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 62. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 63. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 64. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 65. ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 66. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 67. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 68. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 69. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 70. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 71. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 72. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 73. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 74. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 75. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 76. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 77. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 78. AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 79. AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 80. AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 81. AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 82. SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 83. SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 84. SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 85. SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 86. REST OF ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 87. REST OF ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 88. REST OF ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 89. REST OF ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 90. LAMEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 91. LAMEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 92. LAMEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 93. LAMEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 94. LAMEA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COUNTRY, 2022-2032 ($MILLION)
• TABLE 95. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 96. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 97. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 98. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 99. MIDDLE EAST PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 100. MIDDLE EAST PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 101. MIDDLE EAST PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 102. MIDDLE EAST PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 103. AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022-2032 ($MILLION)
• TABLE 104. AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022-2032 ($MILLION)
• TABLE 105. AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022-2032 ($MILLION)
• TABLE 106. AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022-2032 ($MILLION)
• TABLE 107. AETNA INC.: KEY EXECUTIVES
• TABLE 108. AETNA INC.: COMPANY SNAPSHOT
• TABLE 109. AETNA INC.: SERVICE SEGMENTS
• TABLE 110. AETNA INC.: PRODUCT PORTFOLIO
• TABLE 111. AETNA INC.: KEY STRATERGIES
• TABLE 112. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (VERADIGM LLC): KEY EXECUTIVES
• TABLE 113. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (VERADIGM LLC): COMPANY SNAPSHOT
• TABLE 114. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (VERADIGM LLC): PRODUCT SEGMENTS
• TABLE 115. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (VERADIGM LLC): PRODUCT PORTFOLIO
• TABLE 116. ATHENAHEALTH: KEY EXECUTIVES
• TABLE 117. ATHENAHEALTH: COMPANY SNAPSHOT
• TABLE 118. ATHENAHEALTH: PRODUCT SEGMENTS
• TABLE 119. ATHENAHEALTH: PRODUCT PORTFOLIO
• TABLE 120. ATHENAHEALTH: KEY STRATERGIES
• TABLE 121. ORACLE CORPORATION: KEY EXECUTIVES
• TABLE 122. ORACLE CORPORATION: COMPANY SNAPSHOT
• TABLE 123. ORACLE CORPORATION: SERVICE SEGMENTS
• TABLE 124. ORACLE CORPORATION: PRODUCT PORTFOLIO
• TABLE 125. ORACLE CORPORATION: KEY STRATERGIES
• TABLE 126. EPIC SYSTEMS CORPORATION: KEY EXECUTIVES
• TABLE 127. EPIC SYSTEMS CORPORATION: COMPANY SNAPSHOT
• TABLE 128. EPIC SYSTEMS CORPORATION: SERVICE SEGMENTS
• TABLE 129. EPIC SYSTEMS CORPORATION: PRODUCT PORTFOLIO
• TABLE 130. EPIC SYSTEMS CORPORATION: KEY STRATERGIES
• TABLE 131. GETWELLNETWORK, INC.: KEY EXECUTIVES
• TABLE 132. GETWELLNETWORK, INC.: COMPANY SNAPSHOT
• TABLE 133. GETWELLNETWORK, INC.: SERVICE SEGMENTS
• TABLE 134. GETWELLNETWORK, INC.: PRODUCT PORTFOLIO
• TABLE 135. GETWELLNETWORK, INC.: KEY STRATERGIES
• TABLE 136. IBM CORPORATION: KEY EXECUTIVES
• TABLE 137. IBM CORPORATION: COMPANY SNAPSHOT
• TABLE 138. IBM CORPORATION: PRODUCT SEGMENTS
• TABLE 139. IBM CORPORATION: PRODUCT PORTFOLIO
• TABLE 140. IQVIA INC.: KEY EXECUTIVES
• TABLE 141. IQVIA INC.: COMPANY SNAPSHOT
• TABLE 142. IQVIA INC.: SERVICE SEGMENTS
• TABLE 143. IQVIA INC.: PRODUCT PORTFOLIO
• TABLE 144. IQVIA INC.: KEY STRATERGIES
• TABLE 145. LUMEON INC.: KEY EXECUTIVES
• TABLE 146. LUMEON INC.: COMPANY SNAPSHOT
• TABLE 147. LUMEON INC.: PRODUCT SEGMENTS
• TABLE 148. LUMEON INC.: PRODUCT PORTFOLIO
• TABLE 149. MCKESSON CORPORATION.: KEY EXECUTIVES
• TABLE 150. MCKESSON CORPORATION.: COMPANY SNAPSHOT
• TABLE 151. MCKESSON CORPORATION.: PRODUCT SEGMENTS
• TABLE 152. MCKESSON CORPORATION.: PRODUCT PORTFOLIO
• TABLE 153. MCKESSON CORPORATION.: KEY STRATERGIES

LIST OF FIGURES

• FIGURE 01. PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032
• FIGURE 02. SEGMENTATION OF PATIENT ENGAGEMENT SOLUTIONS MARKET,2022-2032
• FIGURE 03. TOP IMPACTING FACTORS IN PATIENT ENGAGEMENT SOLUTIONS MARKET (2022 TO 2032)
• FIGURE 04. TOP INVESTMENT POCKETS IN PATIENT ENGAGEMENT SOLUTIONS MARKET (2023-2032)
• FIGURE 05. LOW THREAT OF NEW ENTRANTS
• FIGURE 06. LOW THREAT OF SUBSTITUTES
• FIGURE 07. LOW INTENSITY OF RIVALRY
• FIGURE 08. LOW BARGAINING POWER OF BUYERS
• FIGURE 09. LOW BARGAINING POWER OF SUPPLIERS
• FIGURE 10. GLOBAL PATIENT ENGAGEMENT SOLUTIONS MARKET:DRIVERS, RESTRAINTS AND OPPORTUNITIES
• FIGURE 11. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT, 2022 AND 2032(%)
• FIGURE 12. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HARDWARE, BY COUNTRY 2022 AND 2032(%)
• FIGURE 13. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SOFTWARE, BY COUNTRY 2022 AND 2032(%)
• FIGURE 14. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR SERVICES, BY COUNTRY 2022 AND 2032(%)
• FIGURE 15. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE, 2022 AND 2032(%)
• FIGURE 16. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ON-PREMISE, BY COUNTRY 2022 AND 2032(%)
• FIGURE 17. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR CLOUD, BY COUNTRY 2022 AND 2032(%)
• FIGURE 18. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY, 2022 AND 2032(%)
• FIGURE 19. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR COMMUNICATION, BY COUNTRY 2022 AND 2032(%)
• FIGURE 20. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR HEALTH TRACKING AND INSIGHTS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 21. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR BILING AND PAYMENTS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 22. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR ADMINISTRATIVE, BY COUNTRY 2022 AND 2032(%)
• FIGURE 23. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR OTHERS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 24. PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER, 2022 AND 2032(%)
• FIGURE 25. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PROVIDERS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 26. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PAYERS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 27. COMPARATIVE SHARE ANALYSIS OF PATIENT ENGAGEMENT SOLUTIONS MARKET FOR PATIENTS, BY COUNTRY 2022 AND 2032(%)
• FIGURE 28. PATIENT ENGAGEMENT SOLUTIONS MARKET BY REGION, 2022 AND 2032(%)
• FIGURE 29. U.S. PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 30. CANADA PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 31. UK PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 32. GERMANY PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 33. FRANCE PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 34. ITALY PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 35. SPAIN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 36. REST OF EUROPE PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 37. CHINA PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 38. JAPAN PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 39. INDIA PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 40. AUSTRALIA PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 41. SOUTH KOREA PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 42. REST OF ASIA-PACIFIC PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 43. LATIN AMERICA PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 44. MIDDLE EAST PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 45. AFRICA PATIENT ENGAGEMENT SOLUTIONS MARKET, 2022-2032 ($MILLION)
• FIGURE 46. TOP WINNING STRATEGIES, BY YEAR (2022-2023)
• FIGURE 47. TOP WINNING STRATEGIES, BY DEVELOPMENT (2022-2023)
• FIGURE 48. TOP WINNING STRATEGIES, BY COMPANY (2022-2023)
• FIGURE 49. PRODUCT MAPPING OF TOP 10 PLAYERS
• FIGURE 50. COMPETITIVE DASHBOARD
• FIGURE 51. COMPETITIVE HEATMAP: PATIENT ENGAGEMENT SOLUTIONS MARKET
• FIGURE 52. TOP PLAYER POSITIONING, 2022
• FIGURE 53. AETNA INC.: NET REVENUE, 2019-2021 ($MILLION)
• FIGURE 54. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (VERADIGM LLC): NET SALES, 2019-2021 ($MILLION)
• FIGURE 55. ALLSCRIPTS HEALTHCARE SOLUTIONS, INC. (VERADIGM LLC): REVENUE SHARE BY SEGMENT, 2021 (%)
• FIGURE 56. ORACLE CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 57. ORACLE CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 58. ORACLE CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 59. IBM CORPORATION: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 60. IBM CORPORATION: RESEARCH & DEVELOPMENT EXPENDITURE, 2020-2022 ($MILLION)
• FIGURE 61. IBM CORPORATION: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 62. IBM CORPORATION: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 63. IQVIA INC.: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 64. IQVIA INC.: REVENUE SHARE BY SEGMENT, 2022 (%)
• FIGURE 65. IQVIA INC.: REVENUE SHARE BY REGION, 2022 (%)
• FIGURE 66. MCKESSON CORPORATION.: NET REVENUE, 2020-2022 ($MILLION)
• FIGURE 67. MCKESSON CORPORATION.: REVENUE SHARE BY SEGMENT, 2022 (%)

According to a new report published by Allied Market Research, titled, "Patient Engagement Solutions Market," The patient engagement solutions market was valued at $17 billion in 2022, and is estimated to reach $50.5 billion by 2032, growing at a CAGR of 11.5% from 2023 to 2032.

Growth in emphasis on automation trends across regions is one of the major driving factors for the patient engagement solution market. It provides many beneficial aspects such as registering new patients and managing their medical history online, scheduling and rescheduling appointments, and others. It also offers to send automatic appointment reminders either via text or voice messages. Thus, there is a growth in demand for real-time identification, monitoring, and response capabilities provided by patient engagement solutions. These factors are further expected to propel the growth of the global patient engagement solution market.

Furthermore, the market is profoundly influenced by considerable expenses related to patient engagement solutions and services. Primarily, these expenses can serve as a deterrent for smaller and medium-sized enterprises (SMEs) with constrained budgets. SMEs may perceive patient engagement solutions as a financial burden, leading to insufficient investment in healthcare measures. In addition, even larger organizations may exhibit hesitation in allocating substantial resources to patient engagement solutions, particularly when faced with competing budgetary demands.

The notable factors positively affecting the patient engagement solutions market include rise in awareness regarding mobile health among people and growing emphasis on electronic health record (HER) reports. However, extensive investments required for healthcare infrastructure and high complexity associated with the integration of advanced solutions with existing healthcare infrastructure components often hinder market growth. However, rise in significance of cloud computing technologies to deliver remote patient monitoring and assistance services offers lucrative market opportunities for the market players.

The patient engagement solution market is segmented on the basis of component, deployment mode, functionality, end user, and region. On the basis of component, the market is segmented into hardware, software, and service. On the basis of deployment mode, the market is bifurcated into on-premise and cloud. On the basis of functionality, the market is segmented into communication, health tracking and insight, billing and payments, administrative, and others. On the basis of end user, the market is segmented into providers, payers and patients. On the basis of region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.

The market players operating in the global patient engagement solutions market. This report further outlines the current trends and key areas of investment. In addition, it includes Porter's five forces analysis to understand the competitive scenario of the industry and role of each stakeholder. The report features the strategies adopted by key market players to maintain their foothold in the market. Furthermore, it highlights the competitive landscape of key market players to increase their market share and sustain intense competition in the industry. The key players operating in the market include Aetna Inc., Allscripts Healthcare Solutions, Inc. (Veradigm LLC), Athenahealth, Oracle Corporation, EPIC Systems Corporation, GetWellNetwork, Inc., IBM Corporation, IQVIA Inc., Lumeon Inc. and McKesson Corporation.

KEY BENEFITS FOR STAKEHOLDERS

• The study provides an in-depth analysis of the patient engagement solutions market forecast along with the current and future trends to explain the imminent investment pockets.
• Information about key drivers, restraints, and opportunities and their impact analysis on patient engagement solutions market trends is provided in the report.
• The Porter's five forces analysis illustrates the potency of the buyers and suppliers operating in the industry.
• The quantitative analysis of the patient engagement solutions market from 2022 to 2032 is provided to determine the market potential.

Additional benefits you will get with this purchase are:

• Quarterly Update and* (only available with a corporate license, on listed price)
• 5 additional Company Profile of client Choice pre- or Post-purchase, as a free update.
• Free Upcoming Version on the Purchase of Five and Enterprise User License.
• 16 analyst hours of support* (post-purchase, if you find additional data requirements upon review of the report, you may receive support amounting to 16 analyst hours to solve questions, and post-sale queries)
• 15% Free Customization* (in case the scope or segment of the report does not match your requirements, 15% is equivalent to 3 working days of free work, applicable once)
• Free data Pack on the Five and Enterprise User License. (Excel version of the report)
• Free Updated report if the report is 6-12 months old or older.
• 24-hour priority response*
• Free Industry updates and white papers.

Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)

• Investment Opportunities
• Market share analysis of players by products/segments
• Regulatory Guidelines
• Additional company profiles with specific to client's interest
• Additional country or region analysis- market size and forecast
• Market share analysis of players at global/region/country level
• SWOT Analysis

Key Market Segments

By End User

• Providers
• Payers
• Patients

By Component

• Hardware
• Software
• Services

By Deployment Mode

• On-premise
• Cloud

By Functionality

• Communication
• Health Tracking and Insights
• Biling and Payments
• Administrative
• Others

By Region

• North America
  • U.S.
  • Canada
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Rest of Europe
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Rest of Asia-Pacific
• LAMEA
  • Latin America
  • Middle East
  • Africa

Key Market Players:

• Aetna Inc.
• Athenahealth
• EPIC Systems Corporation
• IBM Corporation
• IQVIA Inc.
• Lumeon Inc.
• Allscripts Healthcare Solutions, Inc. (Veradigm LLC)
• Oracle Corporation
• GetWellNetwork, Inc.
• McKesson Corporation.

TABLE OF CONTENTS

CHAPTER 1: INTRODUCTION

• 1.1. Report description
• 1.2. Key market segments
• 1.3. Key benefits to the stakeholders
• 1.4. Research methodology
  • 1.4.1. Primary research
  • 1.4.2. Secondary research
  • 1.4.3. Analyst tools and models

CHAPTER 2: EXECUTIVE SUMMARY

• 2.1. CXO Perspective

CHAPTER 3: MARKET OVERVIEW

• 3.1. Market definition and scope
• 3.2. Key findings
  • 3.2.1. Top impacting factors
  • 3.2.2. Top investment pockets
• 3.3. Porter's five forces analysis
  • 3.3.1. Low threat of new entrants
  • 3.3.2. Low threat of substitutes
  • 3.3.3. Low intensity of rivalry
  • 3.3.4. Low bargaining power of buyers
  • 3.3.5. Low bargaining power of suppliers
• 3.4. Market dynamics
  • 3.4.1. Drivers
    • 3.4.1.1. Rise in awareness regarding mobile health among people
    • 3.4.1.2. Growth in emphasis on electronic health record (EHR) reports
  • 3.4.2. Restraints
    • 3.4.2.1. Extensive investments required for healthcare infrastructure
    • 3.4.2.2. High complexity associated with the integration of advanced solutions with existing healthcare infrastructure components
  • 3.4.3. Opportunities
    • 3.4.3.1. Rise in significance of cloud computing technologies to deliver remote patient monitoring and assistance services

CHAPTER 4: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY COMPONENT

• 4.1. Overview
  • 4.1.1. Market size and forecast
• 4.2. Hardware
  • 4.2.1. Key market trends, growth factors and opportunities
  • 4.2.2. Market size and forecast, by region
  • 4.2.3. Market share analysis by country
• 4.3. Software
  • 4.3.1. Key market trends, growth factors and opportunities
  • 4.3.2. Market size and forecast, by region
  • 4.3.3. Market share analysis by country
• 4.4. Services
  • 4.4.1. Key market trends, growth factors and opportunities
  • 4.4.2. Market size and forecast, by region
  • 4.4.3. Market share analysis by country

CHAPTER 5: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY DEPLOYMENT MODE

• 5.1. Overview
  • 5.1.1. Market size and forecast
• 5.2. On-premise
  • 5.2.1. Key market trends, growth factors and opportunities
  • 5.2.2. Market size and forecast, by region
  • 5.2.3. Market share analysis by country
• 5.3. Cloud
  • 5.3.1. Key market trends, growth factors and opportunities
  • 5.3.2. Market size and forecast, by region
  • 5.3.3. Market share analysis by country

CHAPTER 6: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY FUNCTIONALITY

• 6.1. Overview
  • 6.1.1. Market size and forecast
• 6.2. Communication
  • 6.2.1. Key market trends, growth factors and opportunities
  • 6.2.2. Market size and forecast, by region
  • 6.2.3. Market share analysis by country
• 6.3. Health Tracking and Insights
  • 6.3.1. Key market trends, growth factors and opportunities
  • 6.3.2. Market size and forecast, by region
  • 6.3.3. Market share analysis by country
• 6.4. Biling and Payments
  • 6.4.1. Key market trends, growth factors and opportunities
  • 6.4.2. Market size and forecast, by region
  • 6.4.3. Market share analysis by country
• 6.5. Administrative
  • 6.5.1. Key market trends, growth factors and opportunities
  • 6.5.2. Market size and forecast, by region
  • 6.5.3. Market share analysis by country
• 6.6. Others
  • 6.6.1. Key market trends, growth factors and opportunities
  • 6.6.2. Market size and forecast, by region
  • 6.6.3. Market share analysis by country

CHAPTER 7: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY END USER

• 7.1. Overview
  • 7.1.1. Market size and forecast
• 7.2. Providers
  • 7.2.1. Key market trends, growth factors and opportunities
  • 7.2.2. Market size and forecast, by region
  • 7.2.3. Market share analysis by country
• 7.3. Payers
  • 7.3.1. Key market trends, growth factors and opportunities
  • 7.3.2. Market size and forecast, by region
  • 7.3.3. Market share analysis by country
• 7.4. Patients
  • 7.4.1. Key market trends, growth factors and opportunities
  • 7.4.2. Market size and forecast, by region
  • 7.4.3. Market share analysis by country

CHAPTER 8: PATIENT ENGAGEMENT SOLUTIONS MARKET, BY REGION

• 8.1. Overview
  • 8.1.1. Market size and forecast By Region
• 8.2. North America
  • 8.2.1. Key market trends, growth factors and opportunities
  • 8.2.2. Market size and forecast, by Component
  • 8.2.3. Market size and forecast, by Deployment Mode
  • 8.2.4. Market size and forecast, by Functionality
  • 8.2.5. Market size and forecast, by End User
  • 8.2.6. Market size and forecast, by country
    • 8.2.6.1. U.S.
    • 8.2.6.1.1. Market size and forecast, by Component
    • 8.2.6.1.2. Market size and forecast, by Deployment Mode
    • 8.2.6.1.3. Market size and forecast, by Functionality
    • 8.2.6.1.4. Market size and forecast, by End User
    • 8.2.6.2. Canada
    • 8.2.6.2.1. Market size and forecast, by Component
    • 8.2.6.2.2. Market size and forecast, by Deployment Mode
    • 8.2.6.2.3. Market size and forecast, by Functionality
    • 8.2.6.2.4. Market size and forecast, by End User
• 8.3. Europe
  • 8.3.1. Key market trends, growth factors and opportunities
  • 8.3.2. Market size and forecast, by Component
  • 8.3.3. Market size and forecast, by Deployment Mode
  • 8.3.4. Market size and forecast, by Functionality
  • 8.3.5. Market size and forecast, by End User
  • 8.3.6. Market size and forecast, by country
    • 8.3.6.1. UK
    • 8.3.6.1.1. Market size and forecast, by Component
    • 8.3.6.1.2. Market size and forecast, by Deployment Mode
    • 8.3.6.1.3. Market size and forecast, by Functionality
    • 8.3.6.1.4. Market size and forecast, by End User
    • 8.3.6.2. Germany
    • 8.3.6.2.1. Market size and forecast, by Component
    • 8.3.6.2.2. Market size and forecast, by Deployment Mode
    • 8.3.6.2.3. Market size and forecast, by Functionality
    • 8.3.6.2.4. Market size and forecast, by End User
    • 8.3.6.3. France
    • 8.3.6.3.1. Market size and forecast, by Component
    • 8.3.6.3.2. Market size and forecast, by Deployment Mode
    • 8.3.6.3.3. Market size and forecast, by Functionality
    • 8.3.6.3.4. Market size and forecast, by End User
    • 8.3.6.4. Italy
    • 8.3.6.4.1. Market size and forecast, by Component
    • 8.3.6.4.2. Market size and forecast, by Deployment Mode
    • 8.3.6.4.3. Market size and forecast, by Functionality
    • 8.3.6.4.4. Market size and forecast, by End User
    • 8.3.6.5. Spain
    • 8.3.6.5.1. Market size and forecast, by Component
    • 8.3.6.5.2. Market size and forecast, by Deployment Mode
    • 8.3.6.5.3. Market size and forecast, by Functionality
    • 8.3.6.5.4. Market size and forecast, by End User
    • 8.3.6.6. Rest of Europe
    • 8.3.6.6.1. Market size and forecast, by Component
    • 8.3.6.6.2. Market size and forecast, by Deployment Mode
    • 8.3.6.6.3. Market size and forecast, by Functionality
    • 8.3.6.6.4. Market size and forecast, by End User
• 8.4. Asia-Pacific
  • 8.4.1. Key market trends, growth factors and opportunities
  • 8.4.2. Market size and forecast, by Component
  • 8.4.3. Market size and forecast, by Deployment Mode
  • 8.4.4. Market size and forecast, by Functionality
  • 8.4.5. Market size and forecast, by End User
  • 8.4.6. Market size and forecast, by country
    • 8.4.6.1. China
    • 8.4.6.1.1. Market size and forecast, by Component
    • 8.4.6.1.2. Market size and forecast, by Deployment Mode
    • 8.4.6.1.3. Market size and forecast, by Functionality
    • 8.4.6.1.4. Market size and forecast, by End User
    • 8.4.6.2. Japan
    • 8.4.6.2.1. Market size and forecast, by Component
    • 8.4.6.2.2. Market size and forecast, by Deployment Mode
    • 8.4.6.2.3. Market size and forecast, by Functionality
    • 8.4.6.2.4. Market size and forecast, by End User
    • 8.4.6.3. India
    • 8.4.6.3.1. Market size and forecast, by Component
    • 8.4.6.3.2. Market size and forecast, by Deployment Mode
    • 8.4.6.3.3. Market size and forecast, by Functionality
    • 8.4.6.3.4. Market size and forecast, by End User
    • 8.4.6.4. Australia
    • 8.4.6.4.1. Market size and forecast, by Component
    • 8.4.6.4.2. Market size and forecast, by Deployment Mode
    • 8.4.6.4.3. Market size and forecast, by Functionality
    • 8.4.6.4.4. Market size and forecast, by End User
    • 8.4.6.5. South Korea
    • 8.4.6.5.1. Market size and forecast, by Component
    • 8.4.6.5.2. Market size and forecast, by Deployment Mode
    • 8.4.6.5.3. Market size and forecast, by Functionality
    • 8.4.6.5.4. Market size and forecast, by End User
    • 8.4.6.6. Rest of Asia-Pacific
    • 8.4.6.6.1. Market size and forecast, by Component
    • 8.4.6.6.2. Market size and forecast, by Deployment Mode
    • 8.4.6.6.3. Market size and forecast, by Functionality
    • 8.4.6.6.4. Market size and forecast, by End User
• 8.5. LAMEA
  • 8.5.1. Key market trends, growth factors and opportunities
  • 8.5.2. Market size and forecast, by Component
  • 8.5.3. Market size and forecast, by Deployment Mode
  • 8.5.4. Market size and forecast, by Functionality
  • 8.5.5. Market size and forecast, by End User
  • 8.5.6. Market size and forecast, by country
    • 8.5.6.1. Latin America
    • 8.5.6.1.1. Market size and forecast, by Component
    • 8.5.6.1.2. Market size and forecast, by Deployment Mode
    • 8.5.6.1.3. Market size and forecast, by Functionality
    • 8.5.6.1.4. Market size and forecast, by End User
    • 8.5.6.2. Middle East
    • 8.5.6.2.1. Market size and forecast, by Component
    • 8.5.6.2.2. Market size and forecast, by Deployment Mode
    • 8.5.6.2.3. Market size and forecast, by Functionality
    • 8.5.6.2.4. Market size and forecast, by End User
    • 8.5.6.3. Africa
    • 8.5.6.3.1. Market size and forecast, by Component
    • 8.5.6.3.2. Market size and forecast, by Deployment Mode
    • 8.5.6.3.3. Market size and forecast, by Functionality
    • 8.5.6.3.4. Market size and forecast, by End User

CHAPTER 9: COMPETITIVE LANDSCAPE

• 9.1. Introduction
• 9.2. Top winning strategies
• 9.3. Product mapping of top 10 player
• 9.4. Competitive dashboard
• 9.5. Competitive heatmap
• 9.6. Top player positioning, 2022

CHAPTER 10: COMPANY PROFILES

• 10.1. Aetna Inc.
  • 10.1.1. Company overview
  • 10.1.2. Key executives
  • 10.1.3. Company snapshot
  • 10.1.4. Operating business segments
  • 10.1.5. Product portfolio
  • 10.1.6. Business performance
  • 10.1.7. Key strategic moves and developments
• 10.2. Allscripts Healthcare Solutions, Inc. (Veradigm LLC)
  • 10.2.1. Company overview
  • 10.2.2. Key executives
  • 10.2.3. Company snapshot
  • 10.2.4. Operating business segments
  • 10.2.5. Product portfolio
  • 10.2.6. Business performance
• 10.3. Athenahealth
  • 10.3.1. Company overview
  • 10.3.2. Key executives
  • 10.3.3. Company snapshot
  • 10.3.4. Operating business segments
  • 10.3.5. Product portfolio
  • 10.3.6. Key strategic moves and developments
• 10.4. Oracle Corporation
  • 10.4.1. Company overview
  • 10.4.2. Key executives
  • 10.4.3. Company snapshot
  • 10.4.4. Operating business segments
  • 10.4.5. Product portfolio
  • 10.4.6. Business performance
  • 10.4.7. Key strategic moves and developments
• 10.5. EPIC Systems Corporation
  • 10.5.1. Company overview
  • 10.5.2. Key executives
  • 10.5.3. Company snapshot
  • 10.5.4. Operating business segments
  • 10.5.5. Product portfolio
  • 10.5.6. Key strategic moves and developments
• 10.6. GetWellNetwork, Inc.
  • 10.6.1. Company overview
  • 10.6.2. Key executives
  • 10.6.3. Company snapshot
  • 10.6.4. Operating business segments
  • 10.6.5. Product portfolio
  • 10.6.6. Key strategic moves and developments
• 10.7. IBM Corporation
  • 10.7.1. Company overview
  • 10.7.2. Key executives
  • 10.7.3. Company snapshot
  • 10.7.4. Operating business segments
  • 10.7.5. Product portfolio
  • 10.7.6. Business performance
• 10.8. IQVIA Inc.
  • 10.8.1. Company overview
  • 10.8.2. Key executives
  • 10.8.3. Company snapshot
  • 10.8.4. Operating business segments
  • 10.8.5. Product portfolio
  • 10.8.6. Business performance
  • 10.8.7. Key strategic moves and developments
• 10.9. Lumeon Inc.
  • 10.9.1. Company overview
  • 10.9.2. Key executives
  • 10.9.3. Company snapshot
  • 10.9.4. Operating business segments
  • 10.9.5. Product portfolio
• 10.10. McKesson Corporation.
  • 10.10.1. Company overview
  • 10.10.2. Key executives
  • 10.10.3. Company snapshot
  • 10.10.4. Operating business segments
  • 10.10.5. Product portfolio
  • 10.10.6. Business performance
  • 10.10.7. Key strategic moves and developments